Increased Central Venous Pressure Is Associated With Impaired Renal Function and Mortality in a Broad Spectrum of Patients With Cardiovascular Disease

Journal of the American College of Cardiology

Volumn 53, Issue 7, 2009, Pages 582-588

  Damman, Kevin ^a   van Deursen, Vincent M ^a   Navis, Gerjan ^a   Voors, Adriaan A ^a   van Veldhuisen, Dirk J ^a   Hillege, Hans L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

central venous pressure; heart catheterization; mortality; prognosis; renal function

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEART CATHETERIZATION; HEART INDEX; HUMAN; INFORMATION PROCESSING; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NETHERLANDS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; UNIVERSITY HOSPITAL;

ADULT; AGED; CARDIOVASCULAR DISEASES; CENTRAL VENOUS PRESSURE; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 59649087169     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.080     Document Type: Article

References (38)

1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
2. Ruilope L.M., van Veldhuisen D.J., Ritz E., and Luscher T.F. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol 38 (2001) 1782-1787
3. Hillege H.L., van Gilst W.H., van Veldhuisen D.J., et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 24 (2003) 412-420
4. Nag S., Bilous R., Kelly W., Jones S., Roper N., and Connolly V. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study. Diabetes Med 24 (2007) 10-17
5. Rahman M., Pressel S., Davis B.R., et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 165 (2005) 936-946
6. Reddan D.N., Szczech L.A., Tuttle R.H., et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 14 (2003) 2373-2380
7. Hillege H.L., Nitsch D., Pfeffer M.A., et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113 (2006) 671-678
8. Ljungman S., Laragh J.H., and Cody R.J. Role of the Kidney in Congestive Heart-Failure - Relationship of Cardiac Index to Kidney-Function. Drugs 39 (1990) 10-21
9. Stam F., van Guldener C., Schalkwijk C.G., ter Wee P.M., Donker A.J.M., and Stehouwer C.D.A. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol Dial Transplant 18 (2003) 892-898
10. Zoccali C., Mallamaci F., and Tripepi G. Inflammation and atherosclerosis in end-stage renal disease. Blood Purif 21 (2003) 29-36
11. Damman K., Navis G., Smilde T.D., et al. Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail 9 (2007) 872-878
12. Unverferth D.V., Magorien R.D., Moeschberger M.L., Baker P.B., Fetters J.K., and Leier C.V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54 (1984) 147-152
13. Drazner M.H., Rame J.E., Stevenson L.W., and Dries D.L. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 345 (2001) 574-581
14. Gardner R.S., Henderson G., and McDonagh T.A. The prognostic use of right heart catheterization data in patients with advanced heart failure: how relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?. J Heart Lung Transplant 24 (2005) 303-309
15. Morley D., and Brozena S.C. Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation. Am J Cardiol 73 (1994) 379-383
16. Smilde T.D., van Veldhuisen D.J., Navis G., Voors A.A., and Hillege H.L. Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction. Circulation 114 (2006) 1572-1580
17. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
18. Harrell Jr. F.E., Lee K.L., Califf R.M., Pryor D.B., and Rosati R.A. Regression modelling strategies for improved prognostic prediction. Stat Med 3 (1984) 143-152
19. Doty J.M., Saggi B.H., Sugerman H.J., et al. Effect of increased renal venous pressure on renal function. J Trauma 47 (1999) 1000-1003
20. Stolarczyk J., and Carone F.A. Effects of renal lymphatic occlusion and venous constriction on renal function. Am J Pathol 78 (1975) 285-296
21. Priebe H.J., Heimann J.C., and Hedley-Whyte J. Effects of renal and hepatic venous congestion on renal function in the presence of low and normal cardiac output in dogs. Circ Res 47 (1980) 883-890
22. Maxwell M.H., Breed E.S., and Schwartz I.L. Renal venous pressure in chronic congestive heart failure. J Clin Invest 29 (1950) 342-348
23. Blake W.D., Wegria R., Keating R.P., and Ward H.P. Effect of increased renal venous pressure on renal function. Am J Physiol 157 (1949) 1-13
24. Kos T., Pacher R., Wimmer A., et al. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Wien Klin Wochenschr 110 (1998) 89-95
25. Palomba H., de Castro I., Neto A.L., Lage S., and Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int 72 (2007) 624-631
26. Bruch C., Rothenburger M., Gotzmann M., et al. Chronic kidney disease in patients with chronic heart failure-impact on intracardiac conduction, diastolic function and prognosis. Int J Cardiol 118 (2007) 375-380
27. Miyazato J., Horio T., Takiuchi S., et al. Left ventricular diastolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus. Diabetes Med 22 (2005) 730-736
28. Ogata C., Horio T., Kamide K., Takiuchi S., and Kawano Y. Association between left ventricular diastolic dysfunction and renal hemodynamic change in patients with treated essential hypertension. Hypertens Res 26 (2003) 971-978
29. Ahmed A., Rich M.W., Sanders P.W., et al. Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol 99 (2007) 393-398
30. Bruch C., Reinecke H., Rothenburger M., et al. Transmitral flow patterns and the presence of chronic kidney disease provide independent and incremental prognostic information in patients with heart failure and systolic dysfunction. J Am Soc Echocardiogr 20 (2007) 989-997
31. Guyton A.C., and Jones C.E. Central venous pressure: physiological significance and clinical implications. Am Heart J 86 (1973) 431-437
32. Magder S., and Bafaqeeh F. The clinical role of central venous pressure measurements. J Intensive Care Med 22 (2007) 44-51
33. Schrier R.W. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?. J Am Coll Cardiol 47 (2006) 1-8
34. Yilmaz M.B., Yalta K., Yontar C., et al. Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine. Cardiovasc Drugs Ther 21 (2007) 431-435
35. Damman K., and Voors A.A. Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Cardiovasc Drugs Ther 21 (2007) 403-404
36. Drazner M.H., Rame J.E., and Dries D.L. Third heart sound and elevated jugular venous pressure as markers of the subsequent development of heart failure in patients with asymptomatic left ventricular dysfunction. Am J Med 114 (2003) 431-437
37. Khairy P., Fernandes S.M., Mayer Jr. J.E., et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery. Circulation 117 (2008) 13-15
38. Pilcher D.V., Scheinkestel C.D., Snell G.I., Davye-Quinn A., Bailey M.J., and Williams T.J. High central venous pressure is associated with prolonged mechanical ventilation and increased mortality after lung transplantation. J Thorac Cardiovasc Surg 129 (2005) 912-918